Imaging studies may be ordered to visualize fat accumulation and assess inflammation and fibrosis
Discover the benefits of GLP-1 weight loss medications, such as Semaglutide and Tirzepatide, available through our weight loss packages in Weatherford
For patients with type 2 diabetes and Hashimoto's, options include: Semaglutide (Ozempic) : Once-weekly injection with robust efficacy for glycemic control, weight loss, and cardiovascular risk reduction Semaglutide (Rybelsus) : Oral daily tablet requiring careful timing with levothyroxine Dulaglutide (Trulicity) : Once-weekly injection with established cardiovascular benefits Liraglutide (Victoza) : Daily injection with cardiovascular risk reduction and extensive long-term safety data Tirzepatide (Mounjaro) : Once-weekly injection combining GLP-1 and GIP receptor agonism, showing superior efficacy in clinical trials For patients with obesity and Hashimoto's, FDA-approved options include: Semaglutide (Wegovy) : Once-weekly injection at higher doses than Ozempic Liraglutide (Saxenda) : Daily injection Tirzepatide (Zepbound) : Once-weekly injection with significant weight loss efficacy The presence of Hashimoto's thyroiditis does not inherently favor one GLP-1 medication over another
Participants were randomized 1:1, with blinded raters assessing depressive severity using the 17-item Hamilton Depression Rating Scale (HAMD-17) at baseline and Day 29
Similarly, for liver patients, glutathione supports liver detoxification processes and aids in protecting liver cells from injury and inflammation
